FMP
Agile Therapeutics, Inc.
AGRX
NASDAQ
Inactive Equity
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
1.51 USD
0.05 (3.31%)
About
ceo
Mr. Alfred F. Altomari
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
exchange
NASDAQ
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
CIK
0001261249
ISIN
US00847L3087
CUSIP
00847L100
Address
500 College Road East
Phone
609 683 1880
Country
US
Employee
19
IPO Date
May 23, 2014
Key Executives
Name
Title
Pay
Year Born
Mr. Geoffrey P. Gilmore
Senior Vice President, Chief Administrat...
494.85k
1966
Ms. Amy Welsh
Senior Vice President & Chief Commercial...
0
1971
Mr. Alfred F. Altomari
Chairman, President & Chief Executive Of...
646.53k
1959
Mr. Robert G. Conway M.E.
Senior Vice President and Chief Corporat...
444.11k
1957
Mr. Scott M. Coiante
Chief Financial Officer, Senior Vice Pre...
436.91k
1967
Dr. Paul Korner M.B.A., M.D.
Senior Vice President & Chief Medical Of...
494.6k
1966
As of December 31, 2024, the total employee count stands at 19, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
